Home › Funds › COOPERMAN LEON G › KZIA

COOPERMAN LEON G position in KZIA

KAZIA THERAPEUTICS LTD · Health Care

COOPERMAN LEON G reported holding 50,000 shares of KZIA (KAZIA THERAPEUTICS LTD) in its Q3 2026 13F filing — a position valued at US$480K, representing 0.01% of its reported portfolio and ranking #40 among its reported holdings. COOPERMAN LEON G has disclosed KZIA holdings in 2 of the last 2 reported quarters, going back to Q2 2026.

Latest position (Q3 2026)50.00K sh
Reported value held$479.75K
Portfolio Weight0.01%
First reportedQ2 2026
Last changeHold
Updated2026-11-16

Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR

How COOPERMAN LEON G's KZIA position evolved

COOPERMAN LEON G first disclosed a stake in KZIA in Q2 2026 at 50,000 shares (US$704K). Across 2 filings, COOPERMAN LEON G held the position steady without any share-count change. The most recent filing (Q3 2026) shows 50,000 shares valued at US$480K.

Quarter by quarter

QuarterSharesValueChange
Q2 2026 50.00K $704.00K New
Q3 2026 50.00K $479.75K Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About KZIA and 13F data

KZIA (KAZIA THERAPEUTICS LTD) is a Health Care company. 56 other funds we track also report a position in KZIA — the largest reported positions include Boxer Capital Management, LLC (US$7.9M), Ikarian Capital, LLC (US$5.6M), Dauntless Investment Group, LLC (US$5.0M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding KZIA

All KZIA fund holders →

FAQ

How long has COOPERMAN LEON G held KZIA?

COOPERMAN LEON G has disclosed KZIA holdings in 2 of the last 2 reported quarters, going back to Q2 2026.

What is COOPERMAN LEON G's current position in KZIA?

As of Q3 2026, COOPERMAN LEON G holds 50.00K shares of KZIA (KAZIA THERAPEUTICS LTD), valued at $479.75K, representing 0.01% of its reported portfolio and ranking #40.

Has COOPERMAN LEON G been buying or selling KZIA?

In the latest 13F filing (Q3 2026), COOPERMAN LEON G held unchanged its position in KZIA.

Which other funds hold KZIA?

Other major institutional holders of KZIA include Boxer Capital Management, LLC, Ikarian Capital, LLC, Dauntless Investment Group, LLC, among 56 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.